J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,210
-60 (-0.53%)
At close: May 28, 2025, 3:30 PM KST

J2KBIO Revenue

In the year 2024, J2KBIO had annual revenue of 33.13B KRW with 16.36% growth. J2KBIO had revenue of 6.76B in the quarter ending December 31, 2024, a decrease of -18.90%.

Revenue
33.13B
Revenue Growth
+16.36%
P/S Ratio
1.93
Revenue / Employee
592.51M
Employees
55
Market Cap
62.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202433.13B4.66B16.36%
Dec 31, 202328.47B12.44B77.60%
Dec 31, 202216.03B1.81B12.75%
Dec 31, 202114.22B360.95M2.60%
Dec 31, 202013.86B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
Samsung Biologics 4,898.69B
LG Energy Solution 25.76T
Hyundai Motor Company 178.98T
Hanwha Aerospace 15.28T
KB Financial Group 14.93T
Kia Corporation 109.25T
Revenue Rankings